HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment.
Saved in:
| Title: | HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment. |
|---|---|
| Authors: | Gandarillas S; Department of Dermatology, Wayne State University, Detroit, MI, United States., Newland ES; Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Toppmeyer D; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States., Stephenson R; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States., Denzin L; Department of Pediatrics, Child Health Institute of New Jersey, Rutgers Medical School, New Brunswick, NJ, United States., Dasgeb B; Department of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2024 Jan 08; Vol. 10, pp. 1288844. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2296-858X |
|---|---|
| DOI: | 10.3389/fmed.2023.1288844 |
